Precision for Medicine's Sofia Baig on adapting & driving the future of clinical research.

Biomarkers are critical for patient selection or patient stratification in therapeutics and informing patient management.

Bridging the gap from preclinical to clinical biomarkers requires a clear plan to ensure feasibility and utility in the clinical setting.

Learn about Precision's recommended strategies for overcoming 4 common challenges in biomarker-driven trials.  

Sourcing and selecting quality samples is vital to success. Learn how to develop and implement a robust biospecimen strategy for immuno-oncology R&D.

As technologies and methodologies advance, so do the potential applications for biospecimens. In this article, we explore seven uses of FFPE.